HEMLIBRA® is the first and only once-weekly subcutaneous treatment for patients with inhibitors

HEMLIBRA self-injection

Once trained by a healthcare provider, a patient may self-inject, or use the help of a caregiver.

  • Advise the patient to follow the recommendations in the Instructions for Use, including proper sharps disposal

The HEMLIBRA Instructions for Use contains more detailed instructions on the preparation and administration of HEMLIBRA.

Important information for administering a HEMLIBRA injection

1. Inspect the vial

2. Choose the appropriate syringes and needles

3. Rotate the injection locations

4. Discard unused HEMLIBRA

Products mentioned are trademarks of their respective owners.

Storage

  • Refrigeration: store between 2ºC to 8ºC (36ºF to 46ºF) in the original carton to protect from light; the product is stable at room temperature for up to 7 cumulative days; do not freeze or shake

Injection Demonstration Video

A step-by-step video for your patients

HEMLIBRA Webcast

Stay up-to-date with informative webcast events

Treating Breakthrough Bleeds

Guidelines for addressing breakthrough bleeds